Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,572 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07041359RecruitingPhase 4
Traditional Chinese medicine for elderly heart disease patients with ongoing symptoms
This trial tests whether traditional Chinese medicine can help elderly patients with coronary heart disease who still have chest pain or discomfort despite standard treatments. It focuses on those who cannot have or have not fully benefited from procedures like stents or bypass surgery.
Beijing, Beijing MunicipalityAges 75–90 - NCT05798624Recruiting
FET pregnancy chances after a prior C-section
This study looks at whether a history of a C-section affects the chance of pregnancy when transferring one frozen, euploid embryo. It may help doctors estimate your odds and plan care for future embryo transfers.
Abu DhabiAges 18–42 - NCT07142304Recruiting
A study of compression gloves and boots to prevent chemo nerve damage
This trial is testing a wearable device (gloves and boots) that applies gentle compression to your hands and feet during chemotherapy. It aims to prevent or reduce nerve damage (numbness, tingling, pain) that some chemotherapy drugs can cause.
Poway, CaliforniaAges 18 years+ - NCT07591298RecruitingPhase 2
SYH2070 injection for homozygous familial high cholesterol
This study tests a new injectable medication (SYH2070) designed to lower cholesterol in people with homozygous familial hypercholesterolemia—a genetic condition that causes extremely high cholesterol levels despite treatment. The goal is to see if this drug safely reduces cholesterol better than current options.
Changsha, HunanAges 18 years+ - NCT07544264Recruiting
Five-Year Knee Replacement Outcomes Study
This study follows patients who receive a new knee joint replacement for severe knee arthritis or similar conditions. Researchers will track how well the artificial knee works and how patients recover over 5 years to ensure the replacement lasts and improves quality of life.
BolognaAges 50–85 - NCT07579936RecruitingPhase 2
SAL056 bone-strengthening treatment for postmenopausal osteoporosis
This study tests a new injectable medication called SAL056 to strengthen bones and prevent fractures in postmenopausal women with osteoporosis. Researchers want to find the best dose and how often to give it.
Beijing, Beijing MunicipalityAges 45–80 - NCT07070674RecruitingPhase 1
Study of AC-003 for steroid-resistant graft-versus-host disease
This trial tests an experimental capsule (AC-003) for people with graft-versus-host disease (aGVHD) after a stem cell transplant, whose aGVHD did not get better with steroids. The goal is to see if it can help control the condition.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT07068932RecruitingPhase 1
Study of SHR-4506 for advanced solid tumors
This trial tests a new drug, SHR-4506, for people with advanced cancers that have stopped responding to standard treatments or cannot be treated with standard options. It aims to see if the drug is safe and helpful.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06676982RecruitingPhase 1
CAR-T cell therapy for advanced liver cancer
This trial tests a new treatment called CNCT19, which uses your own immune cells to fight liver cancer. It's for people with advanced liver cancer that hasn't responded to standard treatments or can't be treated with surgery or local procedures.
Hangzhou, ZhejiangAges 18–80 - NCT06074679Recruiting
Single incision gallbladder surgery for acute cholecystitis
This study tests whether removing the gallbladder through a single small cut (single incision laparoscopic cholecystectomy) is safe and effective for people with acute cholecystitis (sudden gallbladder inflammation). It may mean less pain and faster recovery than traditional surgery.
Huangshan City, AnhuiAges 18–70 - NCT07338344RecruitingPhase 2
Luspatercept with thalidomide for beta-thalassemia patients
This study tests whether a combination of two drugs, luspatercept and thalidomide, can help people with beta-thalassemia who need regular blood transfusions. It aims to reduce the number of transfusions needed.
Shenzhen, GuangdongAges 18–75 - NCT05985642Recruiting
HIV treatment interruption study for long-term participants
This study looks at people with HIV who have already taken a break from their HIV medications (called an analytic treatment interruption, or ATI) as part of another study. It aims to understand how well the body can control the virus during longer breaks from treatment, up to 96 weeks.
San Francisco, CaliforniaAges 18 years+ - NCT06625957RecruitingPhase 3
NTCB02-1 trial for patients needing IV nutrition
This trial tests an investigational IV nutrition product called NTCB02-1 in patients who need nutrition through a vein (parenteral nutrition) for at least 3 days. It aims to see if it is safe and works well.
Gyeonggi-do, Goyang-siAges 19 years+ - NCT07595432Recruiting
Vision Technique for Cataract Lens Implant Patients
This study tests a new way to measure and optimize vision in patients who have already had cataract surgery with a lens implant. Researchers want to see if this technique helps patients see as clearly as possible.
ManilaAges 21 years+ - NCT05288803Recruiting
Personalized rehab plans for veterans after knee replacement
This study tests whether customizing a recovery plan (“trajectory”) can improve rehabilitation for veterans after total knee replacement surgery. You may be eligible if you start outpatient rehab soon after surgery at participating clinics.
Aurora, ColoradoAges 40–90 - NCT06752551Recruiting
Apprehension training vs standard physical therapy for shoulder dislocation in military
This study compares a new type of training focused on controlling shoulder 'apprehension' (the feeling that your shoulder might pop out) with standard physical therapy. It is for military personnel who have had a shoulder dislocation and may help you regain trust in your shoulder without surgery.
Be’er Ya‘aqovAges 18–39 - NCT06753110Recruiting
Long-term safety of OPRA implant for arm amputees
This study checks the long-term safety and how well the OPRA implant (a bone-anchored prosthetic) works for people who have an arm amputation. It is for those who already have the implant and had their second surgery at least six months ago.
Melbourne, VictoriaAges Any age - NCT07318818RecruitingPhase 1/Phase 2
Revised cell therapy for recurrent brain cancer
This trial tests a new cell therapy (P134 cells) for people whose glioblastoma has come back after standard treatments like radiation or chemotherapy. The therapy uses a patient's own immune cells (PBMCs) to target cancer cells that have specific markers (CD44 or CD133). It also requires a small procedure to place a reservoir under the scalp for drug delivery.
BeijingAges 18–70 - NCT06960343Recruiting
Shoulder repair with fat tissue for better healing
This trial tests whether adding a small amount of your own fat tissue to standard shoulder surgery helps the torn tendons heal better and last longer. It is for people with a full-thickness tear of the supraspinatus and infraspinatus tendons that needs arthroscopic repair.
Milan, ItalyAges 18 years+ - NCT07317154RecruitingPhase 1
Dendritic cell vaccine for HPV type 6 recurrent respiratory papillomatosis
This Phase 1 trial is testing a vaccine made from your own immune cells (dendritic cells) that may help your body fight the virus causing recurrent papillomas in your voice box. It is for people whose papillomas are caused by HPV type 6, who have had at least one recurrence in the past year.
Scottsdale, ArizonaAges 18 years+ - NCT07529275Recruiting
iCover Stent Safety and Performance in Complex Aortic Aneurysm Repair
This trial tests a special covered stent (iCover) used during a minimally invasive procedure to repair complex abdominal aortic aneurysms—life-threatening bulges in the main artery in your belly. The stent helps keep important blood vessels open during the repair.
BonheidenAges 55 years+ - NCT05771688Recruiting
Balloon procedure for severe left lung birth defect
This trial studies a fetal procedure where doctors place a small balloon to help a severe left-sided lung birth defect (CDH) develop better. It aims to improve baby outcomes by temporarily blocking the airway in the womb, starting in a specific week range of pregnancy.
Minneapolis, MinnesotaAges 18 years+ - NCT07302802Recruiting
Semaglutide for weight loss in teens with genetic obesity
This trial studies whether semaglutide (a once-weekly injection) helps adolescents with a specific genetic form of obesity lose weight. It is for teens who are already being prescribed semaglutide as part of their regular care.
ParisAges 12–21 - NCT06759831Recruiting
Clinical outcomes of living and deceased donor kidney transplants
This study looks at how well kidney transplants work from both living and deceased donors. It may help doctors better understand long-term outcomes for people who get a new kidney.
Bologna, BOAges 18 years+
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,572 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.